Transcription of Medication Nephrotoxic Effects - CKD Pathway
{{id}} {{{paragraph}}}
Example: bachelor of science
Medication Nephrotoxic Effects - CKD Pathway
The Chronic Kidney Disease (CKD) Clinical Pathway is a resource for primary care providers to aid in the diagnosis, medical management, and referral of adults with drugs that may have Nephrotoxic effectsOtherMedicationNephrotoxic EffectsAcetaminophen, aspirinChronic interstitial nephritisAllopurinol (Zyloprim)Acute interstitial nephritisAmitriptyline (Elavil), doxepin (Zonalon), fluoxetine (Prozac)RhabdomyolysisBenzodiazepinesRha bdomyolysisClopidogrel (Plavix), ticlopidine (Ticlid)Thrombotic microangiopathyDiphenhydramine (Benadryl), doxylamine (Unisom)RhabdomyolysisGold therapyGlomerulonephritisHaloperidol (Haldol)RhabdomyolysisPamidronate (Aredia)GlomerulonephritisPhenytoin (Dilantin)Acute interstitial nephritisRanitidine (Zantac)Acute interstitial nephritisStatinsRhabdomyolysisTriamteren eCrystal nephropathyZoledronate (Zometa)Acute kidney injury (AKI)The Chronic Kidney Disea
The Chronic Kidney Disease (CKD) Clinical Pathway is a resource for primary care providers to aid in the diagnosis, medical management, and referral of adults with CKD.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: